UPDATE: Wedbush Upgrades USANA Health Sciences to Neutral on Strong Asia, MLM Sell-Off
Posted on February 07, 2013 at 08:04 AM EST
Wedbush upgraded USANA Health Sciences (NYSE: USNA ) from Underperform to Neutral and maintained a $40.00 price target. Wedbush noted, "Our earlier concerns over N. America recruiting trends, which remain down single digits in the face of emerging competitor ARIIX (which was formed last year by former senior USANA